Tokyo, Aug 3, 2006 (JCN) - Astrazeneca announced on July 26 that it received approval for its Pulmicort Respules for pediatric asthma infants from 6 months to under 5 years old, from the Japanese Ministry of Health, Labor and Welfare. This is the first and only inhaled nebolized corcicosteroid approved for infants and children with asthma in Japan.
